BIOTON Statistics

Total Valuation

BIOTON has a market cap or net worth of PLN 317.70 million. The enterprise value is 367.30 million.

Market Cap	317.70M
Enterprise Value	367.30M

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

BIOTON has 85.86 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	85.86M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.57%
Float	28.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.53
PB Ratio	0.54
P/TBV Ratio	0.87
P/FCF Ratio	12.64
P/OCF Ratio	8.75
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.51, with an EV/FCF ratio of 14.61.

EV / Earnings	-23.46
EV / Sales	1.77
EV / EBITDA	15.51
EV / EBIT	n/a
EV / FCF	14.61

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.10.

Current Ratio	1.08
Quick Ratio	0.29
Debt / Equity	0.10
Debt / EBITDA	2.39
Debt / FCF	2.25
Interest Coverage	-0.75

Financial Efficiency

Return on equity (ROE) is -2.62% and return on invested capital (ROIC) is -0.53%.

Return on Equity (ROE)	-2.62%
Return on Assets (ROA)	-0.44%
Return on Invested Capital (ROIC)	-0.53%
Return on Capital Employed (ROCE)	-0.86%
Revenue Per Employee	572,350
Profits Per Employee	-43,135
Employee Count	359
Asset Turnover	0.26
Inventory Turnover	1.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.43% in the last 52 weeks. The beta is 0.41, so BIOTON's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+5.43%
50-Day Moving Average	3.68
200-Day Moving Average	3.44
Relative Strength Index (RSI)	58.30
Average Volume (20 Days)	31,708

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIOTON had revenue of PLN 207.76 million and -15.66 million in losses. Loss per share was -0.18.

Revenue	207.76M
Gross Profit	64.84M
Operating Income	-5.63M
Pretax Income	-11.88M
Net Income	-15.66M
EBITDA	18.80M
EBIT	-5.63M
Loss Per Share	-0.18

Full Income Statement

Balance Sheet

The company has 6.96 million in cash and 56.57 million in debt, giving a net cash position of -49.61 million or -0.58 per share.

Cash & Cash Equivalents	6.96M
Total Debt	56.57M
Net Cash	-49.61M
Net Cash Per Share	-0.58
Equity (Book Value)	590.55M
Book Value Per Share	6.88
Working Capital	10.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 36.33 million and capital expenditures -11.18 million, giving a free cash flow of 25.14 million.

Operating Cash Flow	36.33M
Capital Expenditures	-11.18M
Free Cash Flow	25.14M
FCF Per Share	0.29

Full Cash Flow Statement

Margins

Gross margin is 31.21%, with operating and profit margins of -2.71% and -7.54%.

Gross Margin	31.21%
Operating Margin	-2.71%
Pretax Margin	-5.72%
Profit Margin	-7.54%
EBITDA Margin	9.05%
EBIT Margin	-2.71%
FCF Margin	12.10%

Dividends & Yields

BIOTON does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.93%
FCF Yield	7.91%

Stock Splits

The last stock split was on January 14, 2014. It was a reverse split with a ratio of 0.01.

Last Split Date	Jan 14, 2014
Split Type	Reverse
Split Ratio	0.01

Scores

BIOTON has an Altman Z-Score of -0.81. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.81
Piotroski F-Score	n/a